<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Fei Su(La Roche College), Jeffrey A. Sosman(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Caroline J. Springer(Cancer Research Center), Qiongqing Wang(La Roche College), Alfonso Zambon(University of Modena and Reggio Emilia), Keith T. Flaherty(Cancer Research Center), Damien Kee(Peter MacCallum Cancer Centre), Nicholas Otte(University of California, Los Angeles), Bartosz Chmielowski(UCLA Health), Richard J. Lee(La Roche College), Luc Andries(HistoGeneX (Belgium)), Kerstin Trunzer(Roche (Switzerland)), Grant A. McArthur(The University of Melbourne), James L. Troy(Medical College of Wisconsin), Igor Puzanov(Roswell Park Comprehensive Cancer Center), Mark Kockx(University of Antwerp), Felipe C. Geyer(Memorial Sloan Kettering Cancer Center), Yan Ma(Gregor Mendel Institute of Molecular Plant Biology), Johannes Noé(Roche (Switzerland)), Bernice H. Wong(Plexxikon (United States)), Dan Niculescu‐Duvaz(Institute of Cancer Research), Natasha Preece(Institute of Cancer Research), Ion Niculescu‐Duvaz(Institute of Cancer Research), Nathalie Dhomen(Institute of Cancer Research), Gideon Bollag(Chan Zuckerberg Biohub San Francisco), Amaya Virós(Cancer Research Center), Elizabeth A. Burton(Children's Hospital of Philadelphia), Olivia Spleiss(Roche (Switzerland)), Stephen Mok(The University of Texas MD Anderson Cancer Center), Carla Milagre(Institute of Cancer Research), Xiangju Kong(University of California, Los Angeles), Matthew J. Martin(Stony Brook University Hospital), Brian Lestini(La Roche College), Richard C. Koya(University of California, Los Angeles), Jorge S. Reis‐Filho(AstraZeneca (France)), Julie S. Hang(La Roche College), Paul B. Chapman(Memorial Sloan Kettering Cancer Center), Robert Hayward(Institute of Cancer Research), Chao Zhang, Hong Yang(La Roche College), Thomas E. Hutson(Texas Tech University), Hoa Nguyen(Plexxikon (United States)), K. B. Nolop(Plexxikon (United States)), Holly Hilton(La Roche College), Min Jung Kim(La Roche College), Maryou Lambros(Institute of Cancer Research), Andrew K. Joe(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gaston Habets(Plexxikon (United States)), Lídia Robert(University of California, Los Angeles), René González(University of Miami)
Cited by 1,028
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k